Coagulation factor and hemostatic protein content of canine plasma after storage of whole blood at ambient temperature.
BACKGROUND
Standard practice in canine blood banking is to produce fresh frozen plasma (FFP) by separating and freezing plasma produced from blood within 8 hours of collection. Within canine blood donation programs, this can limit the number of units collected.


OBJECTIVE
The aim was to compare the coagulation factor and hemostatic protein content (CF&HPC) of plasma produced from blood stored at ambient temperature for 8, 12, and 24 hours. Another aim was to compare the CF&HPC between Greyhound types and other breeds.


METHODS
None.


METHODS
In vitro study. A convenience sample of 58 units of canine blood from a blood donor pool was processed to prepare and freeze plasma 8, 12, or 24 hours following collection.


RESULTS
Regardless of time of processing, the units contained therapeutic CF&HPC. Frozen plasma prepared after 24 hours had significantly higher factor VIII (P = .014) and factor X (P = .03) when compared with the frozen plasma prepared at 8 hours. Factor X (P < .01), fibrinogen (P < .01), and vWF (P = .04) were significantly lower in plasma collected from Greyhound types than in plasma collected from other breeds.


CONCLUSIONS
Storing whole blood for up to 24 hours is a suitable method for producing FFP. Lower values for some coagulation factors and hemostatic proteins in plasma produced from Greyhound types would not preclude these dogs as FFP donors.
Pet Blood Bank UK, Loughborough Technology Centre, Loughborough, UK.
J E
JE
Walton
A S
AS
Hale
M B
MB
Brooks
A K
AK
Boag
W
W
Barnett
R
R
Dean
D000818:Animals; D001779:Blood Coagulation Factors / Q000032:analysis*; D001800:Blood Specimen Collection / Q000662:veterinary; D004285:Dogs / Q000097:blood*; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D008297:Male; D011516:Prothrombin / Q000032:analysis; D013045:Species Specificity; D014841:von Willebrand Factor / Q000032:analysis
D001779:Blood Coagulation Factors; D014841:von Willebrand Factor; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005340:Fibrinogen
Factor VIII; Hemostasis; Transfusion; von Willebrand factor